Novel approaches to treating advanced systemic mastocytosis
JA Gilreath,1 L Tchertanov,2 MW Deininger31Department of Pharmacotherapy, College of Pharmacy and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA; 2Centre de Mathématiques et de Leurs Applications (CMLA-CNRS), ENS ...
Gilreath JA, Tchertanov L, Deininger MW
doaj
Critical care management of systemic mastocytosis: when every wasp is a killer bee [PDF]
core +1 more source
Anaphylaxis events in the PIONEER study of avapritinib in indolent systemic mastocytosis. [PDF]
Pongdee T +17 more
europepmc +1 more source
Nemolizumab as an Alternative Therapeutic Option for Indolent Systemic Mastocytosis. [PDF]
Minbaeva S, Tyring SK.
europepmc +1 more source
Symptom patterns before and after indolent systemic mastocytosis: A matched cohort analysis. [PDF]
Tse KY +13 more
europepmc +1 more source
Refractory cutaneous symptoms in systemic mastocytosis. [PDF]
Gleason L +5 more
europepmc +1 more source
Avapritinib and corticosteroids in advanced systemic mastocytosis with tumoral CMML and associated thrombocytopenia. [PDF]
Abakarim O +7 more
europepmc +1 more source
Systemic Mastocytosis, KIT and the Effects of KIT Tyrosine Kinase Inhibitors on Mast Cell and Basophil Activation. [PDF]
Valent P +15 more
europepmc +1 more source
Using natural language processing to identify symptoms in systemic mastocytosis. [PDF]
Xie F +13 more
europepmc +1 more source

